Sign in to view content

Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial

Gustavo Barreto de Melo, MD, PhD, FASRS

Video
Published 2020

Related

Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA
Diana V Do, MD, FASRS
Annual Meeting Talks
2022
VERONA: End-of-Study Results From a Phase 2 Trial of EYP-1901 (Vorolanib Intravitreal Insert) vs Aflibercept for Diabetic Macular Edema
Yasha S Modi, MD
Updates from the Field
2025
New Therapeutics for Uveitis and Best Uveitis Cases
Sunil Srivastava, MD
Updates from the Field
2017

Category: AMD-Neovascular

See more